Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

NCT02474420 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia
Iron Overload

Interventions

DRUG: Amlodipine
DRUG: Deferasirox

Sponsor

Kevin H.M. Kuo, MD, MSc, FRCPC